TY  - CHAP
M1  - Book, Section
TI  - Chapter 68. Anemia and Blood Transfusion
A1  - Luce, Judith A.
A2  - Hall, Jesse B.
A2  - Schmidt, Gregory A.
A2  - Wood, Lawrence D.H.
Y1  - 2005
N1  - 
T2  - Principles of Critical Care, 3e
AB  - The  current  practice  of  transfusion  in  the  ICU  is  conservative,  reflecting  a  balance  between  the  benefits  and  adverse  consequences  of  transfused  blood.Anemia  developing  in  the  ICU  should  not  be  attributed  solely  to  phlebotomy;  red  cell  loss,  destruction,  or  underproduction  should  also  be  considered.Evaluation  of  the  basis  for  anemia,  beginning  with  analysis  of  the  blood  smear,  reticulocyte  count,  and  red  cell  indices,  may  lead  to  easier  management  of  the  anemia  and  may  prove  useful  in  overall  treatment.For  most  critically  ill  patients,  a  transfusion  target  for  hemoglobin  of  7  to  9  g/dL  is  at  least  as  safe  as  a  higher  threshold  of  10  to  12  g/dL;  the  lower  value  may  be  superior.Transfusion  is  rarely  associated  with  life-threatening  complications  such  as  transfusion-related  acute  lung  injury,  major  hemolysis,  or  lethal  infection.Erythropoietin  and  oxygen-carrying  blood  substitutes  remain  unproven  for  critically  ill  patients.Massively  transfused  patients  are  at  risk  for  hypothermia  and  dilutional  coagulopathy.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2023/11/28
UR  - accessanesthesiology.mhmedical.com/content.aspx?aid=2293268
ER  -